Molecular Imaging, Inc. is a specialty CRO combining expertise in small animal in-vivo pharmacology and imaging. Our unique pharmaco-IMAGING platform allows for enhanced decision making in your discovery and development programs.
For over 10 years, Molecular Imaging has provided pharmacology services and pioneered the application of multi-modality imaging. We have executed over 2,500 studies, 500 of which involved imaging, to more than 150 pharmaceutical and biotechnology clients.
In the News
View Dr. W.R. Leopold's presentation from Molecular TriCon on Enhancing the Predictive Power of Preclinical Models. Click Here
Preclinical Contract Research Organisation specializing in Multi-Modality Imaging studies across a wide range of Therapeutic Areas that enhance the effectiveness and efficiency of R&D decision making efforts for new drugs, biologics, devices and diagnostics.